Inogen (INGN)
(Delayed Data from NSDQ)
$9.25 USD
+0.22 (2.44%)
Updated Jul 19, 2024 04:00 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Price, Consensus and EPS Surprise
INGN 9.25 +0.22(2.44%)
Will INGN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INGN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for INGN
Penumbra (PEN) Soars 3.3%: Is Further Upside Left in the Stock?
OrthoPediatrics (KIDS) Soars 7.5%: Is Further Upside Left in the Stock?
INGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Asensus Surgical (ASXC) Inks a Merger Agreement With KARL STORZ
Other News for INGN
3 Stocks Under $10 With the Potential for Massive Gains
Offerpad Solutions: Now Is The Time To Go Against The Crowd
Inogen to Report Second Quarter 2024 Financial Results on August 6, 2024
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
Inogen Annual Meeting: Strategic Direction and Governance Outcomes